MRNY ETF Overview
The YieldMax® MRNA Option Income Strategy ETF (MRNY) is an actively managed ETF designed to generate weekly income by selling call spreads on Moderna Inc (MRNA).
- Provider: YieldMax
- Asset Class: Options Income ETF
Investment Strategy
Weekly Income Potential The fund is designed to provide investors with the potential opportunity for consistent weekly income through a call spread writing strategy.
MRNY Dividend Yield Analysis
Based on MRNY's trailing 90-day distribution run-rate and its current price of $14.51, CRADY estimates an annualized distribution yield of 103.4%. This figure reflects recent actual payments extrapolated to a full year — not a guaranteed or contractual yield. High distribution yields on option-income ETFs often come from a mix of option premium and return of capital, which can affect the fund's share price over time.
MRNY Distribution Summary
Over its last 12 payments (2026-05-15 to 2026-07-31), MRNY paid a combined $3.33 per share, averaging $0.2773 per distribution (ranging from $0.1838 to $0.4269).
For the full payment-by-payment history and CRADY's next-payment forecast, see the MRNY Next Dividend Prediction.
MRNY Payout Frequency
MRNY pays distributions on a weekly schedule, based on its recent distribution history.
MRNY Fund Information
- Expense Ratio
- 1.00%
- AUM
- $108.41M
- Inception Date
- 2023-10-23
Frequently Asked Questions
MRNY's estimated annualized distribution yield is 103.4%, based on its trailing 90-day payment run-rate.
MRNY pays distributions on a weekly schedule.
Weekly Income Potential The fund is designed to provide investors with the potential opportunity for consistent weekly income through a call spread writing strategy.
자주 묻는 질문
MRNY의 최근 90일 배당 기준 연환산 예상 수익률은 약 103.4%입니다.
MRNY는 주간 배당을 지급합니다.